期刊文献+

癫患者事件相关电位和血浆单胺类神经递质水平的改变及其关系 被引量:1

Changes and their correlation of event-related potential and the plasma levels of monoamine neurotransmitter in patients with epilepsy
在线阅读 下载PDF
导出
摘要 目的探讨癫患者事件相关电位(ERP)和血浆单胺类神经递质水平的改变及其相关性。方法对50例癫患者进行ERP和血浆去甲肾上腺素(NE)、多巴胺(DA)和5-羟色胺(5-HT)水平检测,并与正常对照组比较。结果与正常对照组比较,癫组ERP的N2、P3波潜伏期延长,P3波幅明显降低(均P<0.01),血浆NE、DA和5-HT水平显著降低(均P<0.01)。癫组ERP的P3波潜伏期与血浆NE、DA和5-HT水平呈负相关(r=-0.33,r=-0.41,r=-0.46,均P<0.01),P3波幅与其呈正相关(r=0.32,r=0.39,r=0.48,均P<0.01)。结论癫患者有ERP异常和血浆单胺类神经递质水平降低;并且ERP异常程度与血浆单胺类神经递质水平相关。 Objective To explore the changes and their correlation of event-related potential (ERP)and the plasma levels of monoamine 'neurotransmitter in the patients with epilepsy. Methods ERP and the plasma levels of noradrenalin ( NE ), dopamine ( DA ) and 5-hydroxytryptamine (5-HT) were tested in 50 patients with epilepsy, and the results were compared with the normal controls. Results The latency of N2, P3 of ERP and the amplitude of P3 in the epilepsy group were significant longer and lower than those in the normal control group( all P 〈 0. 01 ). The plasma levels of NE,DA and 5-HT in the epilepsy group were significant lower than those in the normal contral group( all P 〈 0. 01 ). Correlation analysis showed that there were negative correlation with latency of P3 of ERP and the level of NE , DA and 5-HT in epilepsy group ( r = - 0. 33, r = - 0.41, r = - 0. 46, all P 〈 0.01 ), and positive correlation with P3 amplitude respectively ( r = 0. 32, r = 0. 39, r = 0.48, all P 〈 0. 01 ). Conclusion Epilepsy patients have abnormal ERP and the plasma levels of monoamine neurotransmitter decrease, and the degree of abnormal ERP are correlated with the plasma levels of monoamine nenrotransmitter.
出处 《临床神经病学杂志》 CAS 北大核心 2009年第2期102-104,共3页 Journal of Clinical Neurology
关键词 癫痫 事件相关电位 单胺类神经递质 epilepsy event-related potential monoamine neurotransmitter
  • 相关文献

参考文献14

二级参考文献146

共引文献96

同被引文献9

  • 1Lee HW, Jung DK, Suh CK, et al. Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up [ J]. Epilepsy Behav, 2006,8:736.
  • 2Reis J, Tergau F, Hamer HM, et al. Topiramate selectively decreases intracortical excitability in human motor cortex [ J ]. Epilepsia, 2002,43 : 1149.
  • 3Zhao Q, Hu Y, Holmes GL. Effect of topiramate on cognitive function and activity level following neonatal seizures [ J ]. Epilepsy Behav, 2005,6:529.
  • 4Baeta E, Santana I, Castro G, et al. Cognitive effects of therapy with topiramate in patients with refractory partial epilepsy [ J ]. Rev Neurol, 2002,34:737.
  • 5Lee S, Sziklas V, Andermann F, et al. The effects of adjunctive topiramate on cognitive function in patients with epilepsy [ J ]. Epilepsia, 2003,44:339.
  • 6Meador KJ, Loring DW, Hulihan JF, et al. Differential cognitive and behavioral effects of topiramate and valproate [ J ]. Neurology, 2003,60 : 1483.
  • 7Crawford P. An audit of topiramate use in a general neurology clinic [J]. Seizure, 1998,7:207.
  • 84th TWO, French JA, Faught E, et al. Postmarketing experience with topiramate and cognition[ J ]. Epilepsia, 2001,42 : 1134.
  • 9Huppertz HJ, Quiske A, Sehulze-Bonhage A. Cognitive impairments due to add-on therapy with topiramate [ J ]. Nervenarzt, 2001,72:275.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部